Doses and ingredients could be different to whats on the label, and it could be contaminated
Bioglutide (NA-931) presents a novel quadruple-agonist mechanism that is scientifically ambitious, targeting GLP-1, GIP, glucagon, and IGF-1 receptors in a single oral molecule
In pregnant rats administered semaglutide during organogenesis, embryofetal mortality, structural abnormalities and alterations to growth occurred at maternal exposures below the maximum recommended human dose (MRHD) based on AUC
Naranjo-Galindo FJ, Ai R, Fang EF, Nilsen HL, SenGupta T (2022) C
It is a logical assumption that if sperm quality is improved that more babies will follow
This long clinical history gives patients and providers added confidence in its safety and efficacy